Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Stoll

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Revue Medicale Suisse|July 21, 2017
[Denosumab in clinical practice : beware before, during and after]Olivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Clinical Rheumatology|November 2, 2012
What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture?Bérengère Aubry-Rozier, Delphine Stoll, Marc-Antoine Krieg, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Revue Medicale Suisse|April 18, 2019
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]Elena Gonzalez Rodriguez, Olivier Lamy, Bérengère Aubry-Rozier, et al.
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Praxis|August 7, 2014
[Atypical fractures of the femur: apropos of 3 clinical cases]Maria Sanduloviciu, Delphine Stoll, Olivier Lamy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases ReportOlivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Medical Case Reports|October 4, 2012
Diffuse nesidioblastosis with hypoglycemia mimicking an insulinoma: a case reportChiara Ferrario, Delphine Stoll, Ariane Boubaker, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|July 21, 2017
[Denosumab in clinical practice : beware before, during and after]Olivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2020
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into AccountElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Clinical Rheumatology|November 2, 2012
What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture?Bérengère Aubry-Rozier, Delphine Stoll, Marc-Antoine Krieg, et al.
Journal of Bone Oncology|August 4, 2020
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252)Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Praxis|June 7, 2018
[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]Olivier Lamy, Elena Gonzalez Rodriguez, Delphine Stoll, et al.
Revue Medicale Suisse|April 18, 2019
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]Elena Gonzalez Rodriguez, Olivier Lamy, Bérengère Aubry-Rozier, et al.
Breast Cancer Research and Treatment|October 11, 2019
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitorsElena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Praxis|August 7, 2014
[Atypical fractures of the femur: apropos of 3 clinical cases]Maria Sanduloviciu, Delphine Stoll, Olivier Lamy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases ReportOlivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
Journal of Medical Case Reports|October 4, 2012
Diffuse nesidioblastosis with hypoglycemia mimicking an insulinoma: a case reportChiara Ferrario, Delphine Stoll, Ariane Boubaker, et al.
Pageof 3